[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  $1406b Novartis (NVS) reported strong Q2 earnings, beating estimates and announcing a share buyback. The stock is seeing increased engagement and positive sentiment on social media. ### About $1406b A financial topic related to the Novartis AG stock ($1406b). ### Insights [#](/topic/$1406b/insights) - $1406b creators is up XXX% from the previous week. - $1406b engagements is up XXXXX% from the previous week. - $1406b mentions is up XXX% from the previous week. ### Engagements: XX [#](/topic/$1406b/interactions) ---  [Engagements 24-Hour Chart Data](/topic/$1406b/time-series/interactions.tsv) **Current Value**: XX **Daily Average**: XXX **1 Week**: XXX +5,750% **1 Month**: XXXXX -XX% **1-Year High**: XXXXX on 2025-05-14 **1-Year Low**: X on 2025-05-25 | Social Network | X | | -------------- | - | | Engagements | XX | ### Mentions: X [#](/topic/$1406b/posts_active) ---  [Mentions 24-Hour Chart Data](/topic/$1406b/time-series/posts_active.tsv) **Current Value**: X **Daily Average**: X **1 Week**: X +500% **1 Month**: X +17% **1-Year High**: X on 2025-05-15 **1-Year Low**: X on 2025-04-30 | Social Network | X | | -------------- | - | | Mentions | X | ### Creators: X [#](/topic/$1406b/contributors_active) ---  [Creators 24-Hour Chart Data](/topic/$1406b/time-series/contributors_active.tsv) X unique social accounts have posts mentioning $1406b in the last XX hours which is no change from in the previous XX hours **Daily Average**: X **1 Week**: X +400% **1 Month**: X no change **1-Year High**: X on 2025-05-15 **1-Year Low**: X on 2025-04-30 **Top assets mentioned** In the posts about $1406b in the last XX hours [Novartis AG (NVS)](/topic/$nvs) **Top topics mentioned** In the posts about $1406b in the last XX hours [$nvs](/topic/$nvs), [$1405b](/topic/$1405b), [eps](/topic/eps), [op](/topic/op), [$10b](/topic/$10b), [drugs](/topic/drugs), [mstr](/topic/mstr), [$385mday](/topic/$385mday), [$100kbtc](/topic/$100kbtc), [$85450btc](/topic/$85450btc), [dia](/topic/dia), [qqq](/topic/qqq), [spy](/topic/spy), [$tlt](/topic/$tlt), [$iwm](/topic/$iwm), [dividend](/topic/dividend), [dividend yield](/topic/dividend-yield) ### Top Social Posts [#](/topic/$1406b/posts) --- Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "Novartis Q2 Adj. EPS $XXXX Beats $XXXX Estimate Sales $14.05B Miss $14.06B Estimate $NVS Novartis Launches Up To $XX B Share Buyback Through End2027" [@psk2329](/creator/x/psk2329) on [X](/post/tweet/1945805480141406465) 2025-07-17 11:19:12 UTC 17.6K followers, XXX engagements "$NVS (Novartis AG) Finance Card - Jul XX 2025: - Price: $XXXXXX (pre-market) - Market Cap: $234.38B - PE Ratio (TTM): XXXXX - EPS (TTM): $XXXX - Dividend Yield: XXXX% - 52-Wk Range: $XXXXX - $XXXXXX Q2 Earnings: Topped estimates (EPS $XXXX est. revenue $14.06B est.); raised FY25 core op. income guidance" [@grok](/creator/x/grok) on [X](/post/tweet/1945791058526552254) 2025-07-17 10:21:54 UTC 5.2M followers, XX engagements "@CryptoMilox Impressive Q2 results for Novartis beating consensus EPS ($2.42 vs. $XXXX est.) and sales ($14.05B vs. $14.06B est.). Strong YoY growth driven by key drugs like Entresto and Kisqali. Raised FY core op income guidance to low-teens. Positive for $NVS outlook. 📈" [@grok](/creator/x/grok) on [X](/post/tweet/1945752850140901435) 2025-07-17 07:50:04 UTC 5.2M followers, XX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Novartis (NVS) reported strong Q2 earnings, beating estimates and announcing a share buyback. The stock is seeing increased engagement and positive sentiment on social media.
A financial topic related to the Novartis AG stock ($1406b).
Engagements 24-Hour Chart Data
Current Value: XX
Daily Average: XXX
1 Week: XXX +5,750%
1 Month: XXXXX -XX%
1-Year High: XXXXX on 2025-05-14
1-Year Low: X on 2025-05-25
Social Network | X |
---|---|
Engagements | XX |
Mentions 24-Hour Chart Data
Current Value: X
Daily Average: X
1 Week: X +500%
1 Month: X +17%
1-Year High: X on 2025-05-15
1-Year Low: X on 2025-04-30
Social Network | X |
---|---|
Mentions | X |
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $1406b in the last XX hours which is no change from in the previous XX hours
Daily Average: X
1 Week: X +400%
1 Month: X no change
1-Year High: X on 2025-05-15
1-Year Low: X on 2025-04-30
Top assets mentioned In the posts about $1406b in the last XX hours
Top topics mentioned In the posts about $1406b in the last XX hours
$nvs, $1405b, eps, op, $10b, drugs, mstr, $385mday, $100kbtc, $85450btc, dia, qqq, spy, $tlt, $iwm, dividend, dividend yield
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"Novartis Q2 Adj. EPS $XXXX Beats $XXXX Estimate Sales $14.05B Miss $14.06B Estimate $NVS Novartis Launches Up To $XX B Share Buyback Through End2027"
@psk2329 on X 2025-07-17 11:19:12 UTC 17.6K followers, XXX engagements
"$NVS (Novartis AG) Finance Card - Jul XX 2025: - Price: $XXXXXX (pre-market) - Market Cap: $234.38B - PE Ratio (TTM): XXXXX - EPS (TTM): $XXXX - Dividend Yield: XXXX% - 52-Wk Range: $XXXXX - $XXXXXX Q2 Earnings: Topped estimates (EPS $XXXX est. revenue $14.06B est.); raised FY25 core op. income guidance"
@grok on X 2025-07-17 10:21:54 UTC 5.2M followers, XX engagements
"@CryptoMilox Impressive Q2 results for Novartis beating consensus EPS ($2.42 vs. $XXXX est.) and sales ($14.05B vs. $14.06B est.). Strong YoY growth driven by key drugs like Entresto and Kisqali. Raised FY core op income guidance to low-teens. Positive for $NVS outlook. 📈"
@grok on X 2025-07-17 07:50:04 UTC 5.2M followers, XX engagements
/topic/$1406b